Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration of CpG-28, a TRL 9 agonist, in patients with neoplastic meningitis (NM). Cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales: Ursu, Renata, Taillibert, Sophie, Banissi, Claire, Vicaut, Eric, Bailon, Olivier, Le Rhun, Emilie, Guillamo, Jean-Sebastien, Psimaras, Dimitri, Tibi, Annick, Sacko, Adama, Marantidou, Athina, Belin, Catherine, Carpentier, Antoine F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582991/
https://www.ncbi.nlm.nih.gov/pubmed/26094710
http://dx.doi.org/10.1111/cas.12724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582991/
https://www.ncbi.nlm.nih.gov/pubmed/26094710
http://dx.doi.org/10.1111/cas.12724

Ejemplares similares